Territory includes: CA, WA, OR, MT, ID, NV, WY, UT, AZ, AK
The Medical Science Liaison (MSL), an extended resource of Medical Affairs, will identify, engage and develop key external experts in the institutional and academic settings, as well as payers and formulary key opinion leaders (KOLs); typically physicians and pharmacists, and other allied healthcare professionals (HCPs) providing disease state information in support of educating HCP audiences about currently marketed and pipeline products. Additionally, the MSL will identify local, regional and national KOLs, interested researchers, and health outcomes research and educational opportunities.
The MSL will support the medical/scientific platform primarily from a scientific, pharmacoeconomic and value proposition perspective in the areas of infectious disease. The MSL will be solidly versed in the clinical data such that the full range of innovative science, clinical, outcome, economic and value aspects of client’s products can be appreciated by the healthcare practitioner, and/or formulary member or Payer.